ACTRN12610000622000尚未招募未知
A randomised trial of infants sleeping in baby hammock vs cot to determine if there is a difference in oxygen desatuartion events and mean oxygen saturation.
niversity of Auckland0 个研究点目标入组 30 人开始时间: 2010年7月29日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- Days 至 12 Weeks（—）
- 性别
- All
入选标准
- •Healthy, normal full term infants
排除标准
- •requires oxygen treatment
- •infants with any current health problem
- •history of significant birth trauma
研究者
相似试验
进行中（未招募）
1 期
A study in healthy volunteers who have first been given respiratory syncytial virus (RSV), looking at the effect of repeat doses of a new drug called PC786, compared with placebo (a dummy drug), on safety and levels of the drug in the blood after it has been inhaled twice a day for up to 5 daysHuman Respiratory Syncytial Virus (RSV)MedDRA version: 20.0 Level: LLT Classification code 10070358 Term: Human respiratory syncytial virus test positive System Organ Class: 100000109842EUCTR2017-002563-18-GBPulmocide Ltd56
进行中（未招募）
不适用
A randomised, double blind, placebo controlled study to Assess The Effect of Antibiotic Therapy on Chronic Rejection in Human Lung Transplantation - Azithromycin StudyPost Lung Transplantation Chronic Rejection identified as bronchiolitis obliterans syndrome (BOS)EUCTR2006-000485-36-GBewcastle upon Tyne Hospitals NHS Trust64
进行中（未招募）
1 期
A randomised, double blind, placebo controlled study to assess the effect of testosterone treatment on arterial stiffness in patients with type 2 diabetes, peripheral vascular disease and hypogonadism. - Testosterone Replacement in Diabetes and Vascular DiseaseMale HypogonadismEUCTR2005-003652-35-GBBarnsley Hospital NHS Foundation Trust30
进行中（未招募）
不适用
A single blind, placebo-controlled, randomised study in mild to moderate Alzheimer's disease patients to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK239512, a selective histamine H3 receptor antagonistAlzheimer's DiseaseEUCTR2007-004117-33-CZGlaxoSmithKline R&D Ltd38
进行中（未招募）
不适用
A single blind, placebo-controlled, randomised study in mild to moderate Alzheimer's disease patients to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK239512, a selective histamine H3 receptor antagonistMedDRA version: 9.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseAlzheimer's DiseaseEUCTR2007-004117-33-GBGlaxoSmithKline R&D Ltd38